Cite
HARVARD Citation
Ellingsen, E. et al. (2022). Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials. Journal for immunotherapy of cancer. 10 (5), p. . [Online].